-transparent.png){kind=logo}
METHODS There is a marked decrease of the right ventricular ejection fraction after the administration of a bolus of endotoxin to sheep. This hemodynamic response may be the result of thromboxane-mediated pulmonary hypertension. Right ventricular function was studied in an ovine model after the administration of endotoxin (1 microgram/kg Escherichia coli) with and without pretreatment with OKY-046, a selective thromboxane synthetase inhibitor. RESULTS OKY-046 attenuated the endotoxin-induced increase in pulmonary arterial pressure and prevented the early decreases in right ventricular ejection fraction and cardiac output. However, thromboxane synthetase inhibition failed to prevent endotoxin-induced hypoxemia. The marked increase in plasma thromboxane concentrations, which is usually seen after the administration of endotoxin, was prevented by pretreating the animals with OKY-046. On the other hand, increased plasma prostacyclin concentrations were observed in sheep treated with the thromboxane synthetase inhibitor. CONCLUSIONS This series of experiments shows that the early endotoxin-induced decrease in right ventricular ejection fraction can be alleviated by the application of OKY-046.
G Redl, and
S Abdi, and
L D Traber, and
R J Nichols, and
J T Flynn, and
D N Herndon, and
D L Traber
February 1989,
Clinical physiology (Oxford, England),
G Redl, and
S Abdi, and
L D Traber, and
R J Nichols, and
J T Flynn, and
D N Herndon, and
D L Traber
July 1986,
American journal of kidney diseases : the official journal of the National Kidney Foundation,
G Redl, and
S Abdi, and
L D Traber, and
R J Nichols, and
J T Flynn, and
D N Herndon, and
D L Traber
August 1987,
Prostaglandins, leukotrienes, and medicine,
G Redl, and
S Abdi, and
L D Traber, and
R J Nichols, and
J T Flynn, and
D N Herndon, and
D L Traber
May 1984,
The Journal of trauma,
G Redl, and
S Abdi, and
L D Traber, and
R J Nichols, and
J T Flynn, and
D N Herndon, and
D L Traber
January 1982,
Advances in shock research,
G Redl, and
S Abdi, and
L D Traber, and
R J Nichols, and
J T Flynn, and
D N Herndon, and
D L Traber
March 1988,
American heart journal,
G Redl, and
S Abdi, and
L D Traber, and
R J Nichols, and
J T Flynn, and
D N Herndon, and
D L Traber
October 1986,
Clinical physiology (Oxford, England),
G Redl, and
S Abdi, and
L D Traber, and
R J Nichols, and
J T Flynn, and
D N Herndon, and
D L Traber
April 1994,
European journal of clinical investigation,
G Redl, and
S Abdi, and
L D Traber, and
R J Nichols, and
J T Flynn, and
D N Herndon, and
D L Traber
October 1986,
Kidney international,
G Redl, and
S Abdi, and
L D Traber, and
R J Nichols, and
J T Flynn, and
D N Herndon, and
D L Traber
January 1992,
Eicosanoids,
